大腸直腸癌篩檢測試管道 - 發展階段、細分市場、區域、監管途徑、關鍵參與者
市場調查報告書
商品編碼
1396029

大腸直腸癌篩檢測試管道 - 發展階段、細分市場、區域、監管途徑、關鍵參與者

Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

出版日期: | 出版商: GlobalData | 英文 150 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

這份報告檢查和分析了用於結直腸癌篩檢測試的管道產品,並提供了全面的信息,包括不同開發階段的產品的比較分析以及正在進行的臨床試驗的數據。我是。

目錄

第 1 章目錄

第 2 章簡介

第三章開發中的產品

  • 大腸癌篩檢測試 - 管道產品:依開發階段劃分
  • 大腸癌篩檢測試 - 管道產品:細分市場
  • 大腸癌篩檢測試 - 管道產品:按地區
  • 大腸癌篩檢測試 - 管道產品:依監管途徑
  • 大腸癌篩檢測試 - 管道產品:依預計核准日期
  • 大腸癌篩檢測試 - 正在進行的臨床試驗

第 4 章大腸直腸癌篩檢測試 - 正在開發的在研產品:按公司劃分

  • 大腸癌篩檢測試公司 - 管道產品:依開發階段劃分
  • 大腸癌篩檢測試 - 管道產品:依開發階段劃分

第五章大腸直腸癌篩檢檢測企業及產品概況

  • Acuamark Diagnostics Inc:公司概況
    • Acuamark Diagnostics Inc:管道產品和正在進行的臨床試驗概述
  • Anixa Diagnostics Corporation:公司概況
    • Anixa Diagnostics Corporation:管道產品和正在進行的臨床試驗概述
  • Arbele Corp:公司概況
    • Arbele Corp:管道產品和正在進行的臨床試驗概述
  • Augusta University:公司概況
    • Augusta University:管道產品和正在進行的臨床試驗概述
  • Bar Harbor BioTechnology Inc(不活躍):公司概況
    • Bar Harbor BioTechnology Inc(不活躍):管道產品和正在進行的臨床試驗概述
  • Beacon Biomedical Inc:公司概況
    • Beacon Biomedical Inc:管道產品和正在進行的臨床試驗概述
  • Beckman Research Institute Of The City Of Hope:公司概況
    • Beckman Research Institute Of The City Of Hope:管道產品和正在進行的臨床試驗概述
  • Beijing Youxun Medical Laboratory Co Ltd:公司概況
    • Beijing Youxun Medical Laboratory Co Ltd:在研產品及正在進行的臨床試驗概覽
  • BGI Genomics Co Ltd:公司概況
    • BGI Genomics Co Ltd:管道產品和正在進行的臨床試驗概述
  • Biocartis Group NV:公司概況
    • Biocartis Group NV:管道產品和正在進行的臨床試驗概述
  • Biome Diagnostics GmbH:公司概況
    • Biome Diagnostics GmbH:管道產品和正在進行的臨床試驗概述
  • Castle Biosciences Inc:公司概況
    • Castle Biosciences Inc:管道產品和正在進行的臨床試驗概述
  • CellMax Life Inc:公司概況
    • CellMax Life Inc:管道產品和正在進行的臨床試驗概述
  • Celtic Medical BV:公司概況
    • Celtic Medical BV:管道產品和正在進行的臨床試驗概述
  • CRC Bioscreen:公司概況
    • CRC Bioscreen:管道產品和正在進行的臨床試驗概述
  • Creative Biosciences (Guangzhou) Co Ltd:公司概況
    • Creative Biosciences (Guangzhou) Co Ltd:在研產品及正在進行的臨床試驗概覽
  • Curo Biosciences Pvt Ltd:公司概況
    • Curo Biosciences Pvt Ltd:管道產品和正在進行的臨床試驗概述
  • Diagen:公司概況
    • Diagen:管道產品和正在進行的臨床試驗概述
  • DiagNodus Ltd:公司概況
    • DiagNodus Ltd:管道產品和正在進行的臨床試驗概述
  • EHang (Suzhou) Biomedical Co Ltd:公司概況
    • EHang (Suzhou) Biomedical Co Ltd:在研產品及正在進行的臨床試驗概覽
  • Epigenomics Inc:公司概況
    • Epigenomics Inc:管道產品和正在進行的臨床試驗概述
  • Exact Sciences Corp:公司概況
    • Exact Sciences Corp:管道產品和正在進行的臨床試驗概述
  • Foundation Medicine Inc:公司概況
    • Foundation Medicine Inc:管道產品和正在進行的臨床試驗概述
  • G Medical Health and Wellness:公司概況
    • G Medical Health and Wellness:管道產品和正在進行的臨床試驗概述
  • Geneoscopy LLC:公司概況
    • Geneoscopy LLC:管道產品和正在進行的臨床試驗概述
  • Genetic Technologies Ltd:公司概況
    • Genetic Technologies Ltd:管道產品和正在進行的臨床試驗概述
  • Genetron Health (Beijing) Co Ltd:公司概況
    • Genetron Health (Beijing) Co Ltd:在研產品及正在進行的臨床試驗概覽
  • Genoptix Inc(不活躍):公司概述
    • Genoptix Inc(不活躍):管道產品和正在進行的臨床試驗概述
  • Guardant Health Inc:公司概況
    • Guardant Health Inc:管道產品和正在進行的臨床試驗概述
  • Human Metabolome Technologies Inc公司概況
    • Human Metabolome Technologies Inc:管道產品和正在進行的臨床試驗概述
  • iCellate Medical AB:公司概況
    • iCellate Medical AB:管道產品和正在進行的臨床試驗概述
  • Interpace Biosciences Inc:公司概況
    • Interpace Biosciences Inc:管道產品和正在進行的臨床試驗概述
  • JL Medi Labs Co Ltd:公司概況
    • JL Medi Labs Co Ltd:管道產品和正在進行的臨床試驗概述
  • Mainz Biomed NV:公司概況
    • Mainz Biomed NV:管道產品和正在進行的臨床試驗概述
  • mBioSys Pvt Ltd:公司概況
    • mBioSys Pvt Ltd:管道產品和正在進行的臨床試驗概述
  • Neuome Peptides Pte Ltd:公司概況
    • Neuome Peptides Pte Ltd:管道產品和正在進行的臨床試驗概述
  • Oncodiag:公司概況
    • Oncodiag:管道產品和正在進行的臨床試驗概述
  • Oncomark Ltd:公司概況
    • Oncomark Ltd:管道產品和正在進行的臨床試驗概述
  • Ourotech Ltd:公司概況
    • Ourotech Ltd:管道產品和正在進行的臨床試驗概述
  • Prenetics Ltd:公司概況
    • Prenetics Ltd:管道產品和正在進行的臨床試驗概述
  • Preora Healthcare Inc:公司概況
    • Preora Healthcare Inc:管道產品和正在進行的臨床試驗概述
  • QuantuMDx Group Ltd:公司概況
    • QuantuMDx Group Ltd:管道產品和正在進行的臨床試驗概述
  • Rarity Bioscience AB:公司概況
    • Rarity Bioscience AB:管道產品和正在進行的臨床試驗概述
  • Rhythm Biosciences Ltd:公司概況
    • Rhythm Biosciences Ltd:管道產品和正在進行的臨床試驗概述
  • Shanghai Singlera Genomics Technologies Co Ltd:公司概況
    • Shanghai Singlera Genomics Technologies Co Ltd:管道產品和正在進行的臨床試驗概述
  • Singlera Genomics Inc:公司概況
    • Singlera Genomics Inc:管道產品和正在進行的臨床試驗概述
  • The Chinese University of Hong Kong:公司概況
    • The Chinese University of Hong Kong:管道產品和正在進行的臨床試驗概述
  • University of Oxford:公司概況
    • University of Oxford:管道產品和正在進行的臨床試驗概述
  • Vastcon Inc:公司概況
    • Vastcon Inc:管道產品和正在進行的臨床試驗概述
  • VolitionRX Ltd:公司概況
    • VolitionRX Ltd:管道產品和正在進行的臨床試驗概述

第 6 章大腸直腸癌篩檢測試 - 最新進展

第七章附錄

Abstract

GlobalData's Medical Devices sector report, "Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Colorectal Cancer Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal Cancer Screening Tests includes Guaiac Fecal Occult Blood Test (gFOBT) Kits, Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits, Fecal DNA Test Kits and Other Colorectal Cancer Screening Tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Screening Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Screening Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Screening Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Colorectal Cancer Screening Tests Overview

3 Products under Development

  • 3.1 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • 3.2 Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • 3.3 Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • 3.4 Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • 3.5 Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • 3.6 Colorectal Cancer Screening Tests - Ongoing Clinical Trials

4 Colorectal Cancer Screening Tests - Pipeline Products under Development by Companies

  • 4.1 Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
  • 4.2 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development

5 Colorectal Cancer Screening Tests Companies and Product Overview

  • 5.1 Acuamark Diagnostics Inc Company Overview
    • 5.1.1 Acuamark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Anixa Diagnostics Corporation Company Overview
    • 5.2.1 Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Arbele Corp Company Overview
    • 5.3.1 Arbele Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Augusta University Company Overview
    • 5.4.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Bar Harbor BioTechnology Inc (Inactive) Company Overview
    • 5.5.1 Bar Harbor BioTechnology Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Beacon Biomedical Inc Company Overview
    • 5.6.1 Beacon Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Beckman Research Institute Of The City Of Hope Company Overview
    • 5.7.1 Beckman Research Institute Of The City Of Hope Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Beijing Youxun Medical Laboratory Co Ltd Company Overview
    • 5.8.1 Beijing Youxun Medical Laboratory Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 BGI Genomics Co Ltd Company Overview
    • 5.9.1 BGI Genomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Biocartis Group NV Company Overview
    • 5.10.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Biome Diagnostics GmbH Company Overview
    • 5.11.1 Biome Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Castle Biosciences Inc Company Overview
    • 5.12.1 Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 CellMax Life Inc Company Overview
    • 5.13.1 CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Celtic Medical BV Company Overview
    • 5.14.1 Celtic Medical BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 CRC Bioscreen Company Overview
    • 5.15.1 CRC Bioscreen Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Creative Biosciences (Guangzhou) Co Ltd Company Overview
    • 5.16.1 Creative Biosciences (Guangzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Curo Biosciences Pvt Ltd Company Overview
    • 5.17.1 Curo Biosciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Diagen Company Overview
    • 5.18.1 Diagen Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 DiagNodus Ltd Company Overview
    • 5.19.1 DiagNodus Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 EHang (Suzhou) Biomedical Co Ltd Company Overview
    • 5.20.1 EHang (Suzhou) Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Epigenomics Inc Company Overview
    • 5.21.1 Epigenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Exact Sciences Corp Company Overview
    • 5.22.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Foundation Medicine Inc Company Overview
    • 5.23.1 Foundation Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 G Medical Health and Wellness Company Overview
    • 5.24.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Geneoscopy LLC Company Overview
    • 5.25.1 Geneoscopy LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Genetic Technologies Ltd Company Overview
    • 5.26.1 Genetic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Genetron Health (Beijing) Co Ltd Company Overview
    • 5.27.1 Genetron Health (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Genoptix Inc (Inactive) Company Overview
    • 5.28.1 Genoptix Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Guardant Health Inc Company Overview
    • 5.29.1 Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Human Metabolome Technologies Inc Company Overview
    • 5.30.1 Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 iCellate Medical AB Company Overview
    • 5.31.1 iCellate Medical AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Interpace Biosciences Inc Company Overview
    • 5.32.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 JL Medi Labs Co Ltd Company Overview
    • 5.33.1 JL Medi Labs Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Mainz Biomed NV Company Overview
    • 5.34.1 Mainz Biomed NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 mBioSys Pvt Ltd Company Overview
    • 5.35.1 mBioSys Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 Neuome Peptides Pte Ltd Company Overview
    • 5.36.1 Neuome Peptides Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 Oncodiag Company Overview
    • 5.37.1 Oncodiag Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 Oncomark Ltd Company Overview
    • 5.38.1 Oncomark Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 Ourotech Ltd Company Overview
    • 5.39.1 Ourotech Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 Prenetics Ltd Company Overview
    • 5.40.1 Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 Preora Healthcare Inc Company Overview
    • 5.41.1 Preora Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 QuantuMDx Group Ltd Company Overview
    • 5.42.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 Rarity Bioscience AB Company Overview
    • 5.43.1 Rarity Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 Rhythm Biosciences Ltd Company Overview
    • 5.44.1 Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45 Shanghai Singlera Genomics Technologies Co Ltd Company Overview
    • 5.45.1 Shanghai Singlera Genomics Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46 Singlera Genomics Inc Company Overview
    • 5.46.1 Singlera Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47 The Chinese University of Hong Kong Company Overview
    • 5.47.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48 University of Oxford Company Overview
    • 5.48.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49 Vastcon Inc Company Overview
    • 5.49.1 Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50 VolitionRX Ltd Company Overview
    • 5.50.1 VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Colorectal Cancer Screening Tests- Recent Developments

7 Appendix

List of Tables

List of Tables

  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • Colorectal Cancer Screening Tests - Ongoing Clinical Trials
  • Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • Colorectal Cancer Screening Tests - Ongoing Clinical Trials